在帕金森病试验中的安慰剂反应
1Parkinson's Disease and Movement Disorders Clinic, Division of Neurology, Department of Medicine, The Ottawa Hospital, Civic Campus, C2 Neurosciences, 1053 Carling Avenue, Ottawa, Ontario K1Y 4E9, Canada.
Neurologic clinics
|November 13, 2025
概括
帕金森病显示出显著的安慰剂反应,受症状严重程度和患者期望的影响. 了解这些影响可以改善临床试验设计和患者护理.
科学领域:
- 神经科学是一个神经科学.
- 临床心理学 临床心理学
背景情况:
- 帕金森病 (PD) 的特点是排列性退化和多巴胺缺乏.
- 在PD中,安慰剂效应得到了充分证实,通常通过超多巴胺激素假说来解释.
研究的目的:
- 探索在帕金森病中安慰剂反应的可变性.
- 确定影响PD患者安慰剂效应的因素.
主要方法:
- 对帕金森病中安慰剂反应现有文献的综述.
- 分析诸如症状严重程度,运动波动和干预类型等因素.
主要成果:
- 在帕金森病中,安慰剂反应因运动和非运动症状而异.
- 诸如症状严重程度,运动波动和患者期望等因素显著影响着安慰剂效应.
结论:
- 尽量减少安慰剂效应对于帕金森病中公正的临床试验至关重要.
- 在临床实践中利用安慰剂反应可能会改善帕金森病患者的治疗结果.
相关概念视频
01:24Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
01:54The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
02:07Blind Procedures
12.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.8K
01:11Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K
01:37Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K